|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Doxorubicin treatment in vivo causes cytochrome C release and cardiomyocyte apoptosis, as well as increased mitochondrial efficiency, superoxide dismutase ac- tivity, and Bcl-2 :Bax ratio 显示文摘 | Childs AC Phaneuf SL Dirks AJ | 2002 | Cancer Res2002，62，16： | 1 |
| 2 | Doxorubicin treatment in vivo causes cytochrome C release and cardiomyocyte apoptosis, as well as increased mitochondrial efficiency, superoxide dismutase activity, and Bcl- 2: Bax ratio 显示文摘 | Childs AC | 2002 | Cancer Res2002，62，： | 1 |
| 3 | Minimal residual disease assessed by multiparameter flow cytometry in multiple myeloma: impact on outcome in the Medical Research Council Myeloma IX Study显示文摘 | Rawstron AC Child JA de Tute RM | 2013 | J Clin Oncol2013，31，20： | 1 |
| 4 | Doxorubicin treatment in vivo causes cytochrome C release and cardiomyocyte apoptosis, as well as increased mitochondrial efficiency, superoxide dismutase activity and bcl-2: Bax ratio 显示文摘 | Childs AC Phaneuf SL Dirks A J | 2002 | Cancer Res2002，62，16： | 1 |
| 5 | The impact of attaining a minimal disease state after high-dose melphalan and autologous transplantation for multiple myeloma 显示文摘 | Davies FE Forsyth PD Rawstron AC Owen RG Pratt G Evans PA Richards SJ Drayson M Smith GM Selby PJ Child JA Morgan GJ | 2001 | Br J Haematol2001，112，3： | 1 |
| 6 | Minimal residual dis- ease assessed by multiparameter flow cytometry in multiple myelo- ma: impact on outcome in the Medical Research Council Myeloma IX Study显示文摘 | Rawstron AC Child JA de Tute RM | 2013 | J ClinOncol2013，31，20： | 1 |
| 7 | Doxorubiein treatment in vivo causes cytochrome C release and cardiomyocyte apoptosis as well as increased mitochondrial efficiency, superoxid dismutase activity, and Bcl-2: Bax ratio 显示文摘 | Childs AC Phaneuf SL Dirks AJ | 2002 | Cancer Res2002，62，16： | 1 |
| 8 | Doxorubicin treatment in vivo causes cytochrome C release and cardiomyocyte apoptosis,as well as increased mitochondrial efficiency,superoxide dismutase activity,and Bcl-2:Bax ratio显示文摘 | Childs AC Phaneuf SL Dirks AJ | | 0，，16： | 1 |
| 9 | Doxorubicin treatment in vivo causes cytochrome C release and cardiomyocyte apoptosis,as well as increased mitochondrial efficiency,superoxide dismutase activity,and Bcl-2∶Bax ratio显示文摘 | Childs AC Phaneuf SL Dirks AJ Phillips T Leeuwenburgh C | 2002 | Cancer Res2002，62，16： | 1 |
| 10 | Minimal residual dis- ease assessed by multiparameter flow cytometry in multiple myelo- ma: impact on outcome in the Medical Research Council Myeloma IX Study显示文摘 | Rawstron AC Child JA de Tute R_M | 2013 | J Clin Oncol2013，31，20： | 1 |
| 11 | Doxorubicin treatment in vivo causes cytochrome C release and car- diomyocyte apoptosis, as well as increased mitochondrialefficiency, superoxide dismutase activity, and Bcl-2: Bax ratio显示文摘 | Childs AC Phaneuf SL Dirks A J | 2002 | Cancer Res2002，，62： | 1 |
| 12 | Polyamine-dependent gene expression显示文摘 | Childs AC Mehta D J Gemer EW | 2003 | Cell Mol Life Sci2003，60，： | 1 |
| 13 | Minimal residual disease assessed by multiparameter flow cytometry in multiplemyeloma: impact on outcome in the Medical Research Council Myeloma IX Study显示文摘 | Rawstron AC Child JA de Tute RM | 2013 | J Clin Oncol2013，31，20： | 1 |
| 14 | Doxorubicin treatment in vivo causes cytochrome C release and cardiomyocyte apoptosis,as well as increased mitochondrial efficiency,superoxide dismutase activity and bcl-2:Bax ratio显示文摘 | Childs AC Phaneuf SL Dirks AJ | 2002 | Cancer Res2002，62，16： | 1 |
| 15 | Clinical features and course of patients with glaucoma with the E50K mutation in the optineurin gene显示文摘 | Aung T Rezaie T Okada K Viswanathan AC Child AH Brice G | 2005 | Invest Ophthalmol Vis Sci2005，46，8： | 1 |
| 16 | Doxorubicin treatment in vivo caused cytochrome c release and cardiomyocyte apoptosis,as well as increased mitochondrial efficiency,superoxide dismutase activity,and Bcl-2:Bax ratio显示文摘 | Childs AC Phaneuf SL Dirks AJ | 2002 | Cancer Res2002，62，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员